Last reviewed · How we verify

Oral potassium supplements

Vrije Universiteit Brussel · FDA-approved active Small molecule Quality 5/100

Oral potassium supplements is a Small molecule drug developed by Vrije Universiteit Brussel. It is currently FDA-approved. Also known as: KCl.

At a glance

Generic nameOral potassium supplements
Also known asKCl
SponsorVrije Universiteit Brussel
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Oral potassium supplements

What is Oral potassium supplements?

Oral potassium supplements is a Small molecule drug developed by Vrije Universiteit Brussel.

Who makes Oral potassium supplements?

Oral potassium supplements is developed and marketed by Vrije Universiteit Brussel (see full Vrije Universiteit Brussel pipeline at /company/vrije-universiteit-brussel).

Is Oral potassium supplements also known as anything else?

Oral potassium supplements is also known as KCl.

What development phase is Oral potassium supplements in?

Oral potassium supplements is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing